96M Introduces Luxury Salon Privé Service in Partnership with Evolution Gaming, Bringing Private High-Stakes Live Casino to Singapore...

Kirby Medical Center Partners with Switchboard, MD to Automate Patient Communication Workflows

Jeep® Brand Adds Sahara Trim to Gladiator Lineup for the First Time, Combining Rugged Capability with Premium Everyday Comfort at...

This Christmas, the Resurrection of Jesus Christ Movie Ignites a Global Faith Movement with the Launch of a Historic Coin By FiNDRE

Palo Alto Hills Golf & Country Club approves $51m clubhouse renovation

Montpelier Nevis Unveils a New Look Ahead of Its 60th Anniversary

European Expansion via Ireland ACE Money Transfer Secures Irish Foothold, Launches Strategic Expansion into Europe

INSP FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important...

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

Study: Channel Marketing Shifts to 'Smart Stability' in 2026

Hyde Engineering + Consulting Appoints David O'Keeffe as Chief Revenue Officer

Peter J. Burns, III Writes for Forbes About Best Practices for Selecting a Bridge Loan Provider

Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its...

Stonetrust Workers' Compensation Announces Expansion into North Carolina

American Drive Acquisition Company Announces Closing of $230 Million Initial Public Offering

SNPS FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important December 30...

Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation

CARMAX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important January 2...

Flores Legal Allies' Deep Dive Investigation Clears SDSU Student in Fatal Collision

Sunlight.com Survey: 1 in 7 Americans Plan To Use GLP-1s in 2026